Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting EGFR in non-small-cell lung cancer.

× No keyword cloud information.

11 in total

Review 1. Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their disease.

Authors: Jorge J Nieva; Peter Kuhn
Journal: Future Oncol Date: 2012-08 Impact factor: 3.404

Review 2. Genome-based versus gene-based theory of cancer: possible implications for clinical practice.

Authors: Natasa Todorovic-Rakovic
Journal: J Biosci Date: 2011-09 Impact factor: 1.826

Review 3. Drug development in oncology: classical cytotoxics and molecularly targeted agents.

Authors: Shivaani Kummar; Martin Gutierrez; James H Doroshow; Anthony J Murgo
Journal: Br J Clin Pharmacol Date: 2006-07 Impact factor: 4.335

4. Gefitinib trial in a fanconi's anemia patient with multiple squamous cell carcinomas and hepatocellular carcinoma.

Authors: Hae Sun Jung; Gun-Woo Byun; Kyoung-Eun Lee; Yeung Chul Mun; Seung Hyun Nam; Jung Mi Kwon; Shi Nae Lee; Seock-Ah Im; Chu-Myong Seong; Soon Nam Lee
Journal: Cancer Res Treat Date: 2005-12-31 Impact factor: 4.679

5. Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice.

Authors: Minjee Kim; Janice K Laramy; Afroz S Mohammad; Surabhi Talele; James Fisher; Jann N Sarkaria; William F Elmquist
Journal: Drug Metab Dispos Date: 2019-01-31 Impact factor: 3.922

Review 6. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.

Authors: Minjee Kim; Sani H Kizilbash; Janice K Laramy; Gautham Gampa; Karen E Parrish; Jann N Sarkaria; William F Elmquist
Journal: Pharm Res Date: 2018-07-12 Impact factor: 4.200

7. Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.

Authors: Honglin Jin; Jonathan F Lovell; Juan Chen; Kenneth Ng; Weiguo Cao; Lili Ding; Zhihong Zhang; Gang Zheng
Journal: Cancer Nanotechnol Date: 2010-11-11

Review 8. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis.

Authors: Zenghui Cheng; Fei Shan; Yuesong Yang; Yuxin Shi; Zhiyong Zhang
Journal: BMC Med Imaging Date: 2017-01-10 Impact factor: 1.930

Review 9. Translational progress on tumor biomarkers.

Authors: Hongwei Guo; Xiaolin Zhou; Yi Lu; Liye Xie; Qian Chen; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal: Thorac Cancer Date: 2015-07-27 Impact factor: 3.500

10. Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.

Authors: Petra Hoffknecht; Amanda Tufman; Thomas Wehler; Theo Pelzer; Rainer Wiewrodt; Martin Schütz; Monika Serke; Jan Stöhlmacher-Williams; Angela Märten; Rudolf Maria Huber; Nicolas J Dickgreber
Journal: J Thorac Oncol Date: 2015-01 Impact factor: 15.609